Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 9:06 pm Purchase | 13G | enGene Holdings Inc. ENGN | Blue Owl Capital Holdings LP | 1,234,760 5.320% | 1,234,760 (New Position) | View |
| 2024-02-14 9:05 pm Purchase | 13G | Orchard Therapeutics plc ORTX | Blue Owl Capital Holdings LP | 15,596,600 6.850% | 15,596,600 (New Position) | View |
| 2024-02-14 9:02 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Blue Owl Capital Holdings LP | 3,122,499 7.410% | 3,122,499 (New Position) | View |
| 2024-02-14 9:01 pm Purchase | 13G | CULLINAN THERAPEUTICS INC CGEM | Blue Owl Capital Holdings LP | 3,419,842 7.990% | 3,419,842 (New Position) | View |
| 2024-02-14 8:57 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Blue Owl Capital Holdings LP | 3,414,468 7.780% | 3,414,468 (New Position) | View |
| 2024-02-14 8:56 pm Purchase | 13G | Syros Pharmaceuticals Inc. SYRS | Blue Owl Capital Holdings LP | 1,493,252 5.740% | 1,493,252 (New Position) | View |
| 2024-02-14 8:55 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Blue Owl Capital Holdings LP | 3,004,199 5.020% | 3,004,199 (New Position) | View |
| 2024-02-14 8:51 pm Purchase | 13G | TOURMALINE BIO INC TRML | Blue Owl Capital Holdings LP | 1,332,302 6.550% | 1,332,302 (New Position) | View |